dismiss

Mark your calendars: the next Clean Sweep Live Auction will be on Thursday, June 21st Click to view the full catalogue

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Ubicación actual:
>
> This Story


Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment

 

 

Ultrasound Homepage

A rural college producing ultrasound experts Behind the scenes at the Oregon Institute of Technology's ultrasound education program

New model boosts flow efficiency of particle accelerators May lead to smaller accelerators, easier to operate at reduced costs

Q&A with Dr. Bruce F. Schroeder, owner of Carolina Breast Imaging Specialists, PLC Why his facility chose automated breast ultrasound and what it has meant for dense breast patients

Glassbeam unveils AI anomaly detection for imaging modality maintenance Allowing better awareness for tube temperature, waterflow changes

US lawmakers seek exemption for medical devices under China tariffs Could hurt US manufacturers' ability to compete globally, and raise healthcare costs

Trump administration halts tariff proposal on Chinese imports... for now The 25 percent tariffs get placed on the back burner

FDA approves new application for Exact Imaging's ExactVu micro-ultrasound Enables the urologist to see detailed changes in the prostatic tissue

This doctor's never in, and that's a good thing How a Washington, DC doctor is bringing back house calls

FDA OK's Innovative Health to reprocess SJM's ViewFlex Xtra ultrasound catheter Part of a larger sea change toward better SUD reprocessing

A look back: The history of ultrasound An innovation launched by the study of bat echolocation

EDAP TMS SA is now the exclusive
distributor of Theraclion's Echopulse system
in France

Theraclion taps EDAP to distribute HIFU system throughout France

por John R. Fischer , Staff Reporter
Theraclion has chosen EDAP TMS SA to be the exclusive distributor of its Echopulse system in France, as part of a new agreement between the two companies.

The noninvasive ablation solution for breast fibroadenomas and benign thyroid nodules is now available to customers with a new option that allows the system to operate as a mobile pay-per-use solution.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



“We just had approval from the French health care system to actually reimburse our benign breast tumor noninvasive solution,” David Caumartin, CEO of Theraclion, told HCB News. “We wanted to partner with someone who already had a pay-per-use business unit, which was the case with EDAP and therefore, it was natural combination for us to work with them to be able to make an echotherapy standard of care for benign breast tumors.”

The Echopulse system uses EDAP’s proprietary HIFU technology to treat breast fibroadenomas and benign thyroid nodules. Treatment with the system can take between 15 and 45 minutes.

The agreement allows EDAP France to expand the use of HIFU technology outside the field of urology. Through the reimbursement, Theraclion gains ten new sites in France.

The mobile pay-per-use solution will assist in the quick implementation of the Forfait Innovation cost-effectiveness study, which compares Echopulse echotherapy to surgery in the treatment of breast fibroadenoma, and will enable quick access among patients to thyroid echotherapy.

“Theraclion is the only one that can propose noninvasive ablation for benign thyroid and benign breast tumors,” he said. “We are proposing this in an outpatient fashion, without general anesthetic, just local. We basically destroy soft tissue lesions in 15, 30, 45 minutes of treatment time in a single session.”

Theraclion’s echotherapy procedure was recently was listed on the website of the British National Institute for Health and Clinical Excellence with guidance on its interventional procedures program (IPP) for the noninvasive treatment of breast fibroadenoma, and also received regulatory approval from the Russian Ministry of Health.

The system has been CE marked since 2012 and is available in Europe and Asia with key markets in Germany and Hong Kong. It is currently undergoing two clinical trials at four sites in the U.S.

Ultrasound Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2018 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS